These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8483792)

  • 1. Synthetic peptides inhibit the interaction of von Willebrand factor-platelet membrane glycoproteins.
    Mohri H; Zimmerman TS; Ruggeri ZM
    Peptides; 1993; 14(2):125-9. PubMed ID: 8483792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
    Williams S; Gralnick H
    Thromb Res; 1987 May; 46(3):457-71. PubMed ID: 3037722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Further evaluation of GPIb binding domain of vWf by synthetic peptides].
    Mohri H; Ohkubo T; Ruggeri ZM; Zimmerman TS
    Rinsho Byori; 1992 Jun; 40(6):639-44. PubMed ID: 1513036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
    Plow EF; Pierschbacher MD; Ruoslahti E; Marguerie GA; Ginsberg MH
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8057-61. PubMed ID: 3877935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor.
    Dardik R; Ruggeri ZM; Savion N; Gitel S; Martinowitz U; Chu V; Varon D
    Thromb Haemost; 1993 Sep; 70(3):522-6. PubMed ID: 8259558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
    De Marco L; Girolami A; Russell S; Ruggeri ZM
    J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
    Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptide from the V3 loop consensus motif with a potent anti-HIV activity inhibits ristocetin-mediated vWF-GPIb interaction.
    Mohri H; Asakura Y; Fukushima J; Kawamoto S; Okubo T; Okuda K
    Peptides; 1997; 18(9):1289-93. PubMed ID: 9392827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746.
    Berliner S; Niiya K; Roberts JR; Houghten RA; Ruggeri ZM
    J Biol Chem; 1988 Jun; 263(16):7500-5. PubMed ID: 2453507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected].
    Gralnick HR; Williams S; McKeown L; Kramer W; Krutzsch H; Gorecki M; Pinet A; Garfinkel LI
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7880-4. PubMed ID: 1518808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
    Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
    Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor.
    Zablocki JA; Miyano M; Rao SN; Panzer-Knodle S; Nicholson N; Feigen L
    J Med Chem; 1992 Dec; 35(26):4914-7. PubMed ID: 1479591
    [No Abstract]   [Full Text] [Related]  

  • 15. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
    Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets.
    Huang TF; Holt JC; Kirby EP; Niewiarowski S
    Biochemistry; 1989 Jan; 28(2):661-6. PubMed ID: 2653425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.